← Open Payments lookup

LISA NAZARENUS: Open Payments

NPI 1225200306 · PORTLAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,613 in 93 payments from 21 companies in 2025. Trend: 2023 $1,781 · 2024 $1,840 · 2025 $1,613

Food & beverage: $1,613
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC11$243
Novo Nordisk Inc11$239
PFIZER INC.9$208
ABBVIE INC.19$206
Lilly USA, LLC15$169
Axsome Therapeutics, Inc.4$99
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$91
AstraZeneca Pharmaceuticals LP3$48
GlaxoSmithKline, LLC.2$42
Takeda Pharmaceuticals U.S.A., Inc.2$40

Products named: XIFAXAN, NURTEC ODT, Ozempic, UBRELVY, Auvelity, CAPLYTA, QULIPTA, JARDIANCE.

Industry payments across TN — which companies pay providers there.